Patients' and Clinicians' Preferences on Outcomes and Medication Attributes for Type 2 Diabetes: a Mixed-Methods Study.
Thomas KaragiannisIoannis AvgerinosMaria ToumpalidouAris LiakosKonstantinos KitsiosGeorgios DimitriadisNikolaos PapanasAlexandra BargiotaIakovos AvramidisAnastasia KatsoulaAnastasios TentolourisThekla ChatziadamidouStathis GiannakopoulosStavros AlexiadisKalliopi KotsaApostolos TsapasEleni BekiariPublished in: Journal of general internal medicine (2020)
Patients and clinicians differ in the perception of the relative importance of treatment outcomes and drug characteristics. Individual patient preferences should be explored and implemented in the therapeutic decision-making for type 2 diabetes.